Unique Start-Up Model
Converge Ventures is not a traditional venture fund or accelerator program. Converge Ventures is focused on highly leveraging resources and funding to efficiently transition technology to market. Converge fills the gap where other investment and start-up strategies fall short.
Converge Maximizes Non Dilutive Development Capital
Converge Ventures’ start-ups leverage universities to access needed labs, expertise, equipment, students and other resources to access fundamental research funding for DoD, DoE, DARPA, NIH, NSF , etc.
Converge Ventures’ start-ups receive free support services from TechLink, Federal Laboratories (CRADA) and the small business support offices in each federal agency.
SBIRs and STTRs are $150,000 for Phase I and $1.5M in funding potential per Converge start-up. Converge is a recognized expert in developing and acquiring SBIRs/STTRs at very high rates.
ODSA supports $50,000 start-up; $250,000 to $500,000 Advanced Manufacturing Program (AMP) Grants and others economic support. Converge has won 100% of AMP grants submitted.
Ohio TVSF has $100,000 to $150,000 per Converge start-up. Converge is 20/20 when submitting proposals in support of start ups.
Through Converge Technologies, Converge Ventures’ start-ups are able to identify and acquire industry (customer) development dollars at very high rates of success. These non dilutive revenue sources exponentially increase success rates. Example projects range from $65,000 to $300,000